Fero Industries in play targeted with big upside (FROI) (FROI.OB)

On Sunday, an email was received at Windows Live Hotmail touting the stock of Fero Industries (FROI) (FROI.OB). The stock tout came from another Hotmail email and was called the "Traders Daily Report." FROI is a $0.55/share stock but is targeted at $1.35/share in the short term and $3.80 in the long term. Details of the FROI, FROI.OB tout follow below.

Fero Industries (FROI) (FROI.OB)

Have You Ever Profited From a Smallcap?

Symbol - FROI
Current - .55
Short Target - 1.35+
Long Target - 3.80+
Rating - 10 of 10

According to Yahoo Finance's stock screener, 221 of 294 stocks which are up 200 percent or more in the past 12 months have market capitalizations of less than $100 million. About two-thirds of the rest of these high-flyers have market caps of $100 million-500 million. Biotech is leading the pack.

According to Yahoo Finance's stock screener, 221 of 294 stocks which are up 200 percent or more in the past 12 months have market capitalizations of less than $100 million. About two-thirds of the rest of these high-flyers have market caps of $100 million-500 million. Biotech is leading the pack.

One such company, Fero Industries, Inc. (OTCBB: FROI - News), recently disclose its growth strategy. FROI's first acquisition target is Pyro Pharmaceuticals, Inc., a boutique developmental stage pharmaceutical company located in Irvine, CA. Pyro's focus is on developing a new class of antibiotics to fight drug resistant bacteria, such as life-threatening MRSA. Today, infectious diseases are the leading cause of death worldwide and the third leading cause of death in the United States after cancer and heart disease and exceeding the totals deaths from AIDS.

Investment Tracker Stock Report